← All sources View original paper →
Wikipedia: Nicotinamide mononucleotide
Encyclopedia article on NMN as a vitamin B₃ derivative and NAD⁺ biosynthetic intermediate—consumer and regulatory context alongside research citations; tertiary navigation for NMN-focused protocols.
Scope
Centers NMN as a biosynthetic stepping stone to NAD⁺ (NAMPT / NRK pathways), with sections on dietary presence, supplement markets, and safety / regulatory framing by jurisdiction.
Evidence discipline
Treat efficacy percentages or “anti-aging” slogans as uncertain unless reproduced in linked PubMed entries (Martens NR crossover, Iida, Mishra, Yamanaka, Timmons, and related NMN trials on this wiki—not the Sutton 2018 early TRE paper, which is meal-timing evidence under time-restricted eating).
Pairing
wikipedia-nicotinamide-adenine-dinucleotide-overview— broader NAD⁺ chemistry when readers need mechanism before product-level detail.nmn-precursorsumbrella protocol — keeps NR + NMN evidence discoverable in one conceptual family.
Outcomes
- otherTertiary article for definitions and outbound references; blood NAD⁺ rises, insulin sensitivity shifts, and adverse-event rates belong to linked clinical papers on NMN protocols in this wiki.